Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Lammens

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Frontiers in Cell and Developmental Biology|January 25, 2021
CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands OutAnna Dal Molin, Mattias Hofmans, Enrico Gaffo, et al.
Oncotarget|September 22, 2016
Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemiaFarzaneh Ghazavi, Barbara De Moerloose, Wouter Van Loocke, et al.
Scientific Reports|February 3, 2021
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemiaMattias Hofmans, Tim Lammens, Barbara Depreter, et al.
Haematologica|August 18, 2022
<i>In vivo</i> stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemiaMaaike Van Trimpont, Amanda M Schalk, Yanti De Visser, et al.
Pediatric Blood & Cancer|January 10, 2019
Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01Barbara De Moerloose, Ardine Reedijk, Geertruida H de Bock, et al.
Haematologica|August 3, 2019
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartmentBarbara Depreter, Karin E Weening, Karl Vandepoele, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Cell Death & Disease|February 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitorsIris H Nelen, Soetkin Leys, Sarah-Lee Bekaert, et al.
Frontiers in Immunology|January 9, 2019
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working GroupSimon Bomken, Jutte van der Werff Ten Bosch, Andishe Attarbaschi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2025
Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignanciesJette J Bakhuizen, Freerk van Dijk, Sebastian B B Bon, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Frontiers in Cell and Developmental Biology|January 25, 2021
CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands OutAnna Dal Molin, Mattias Hofmans, Enrico Gaffo, et al.
Oncotarget|September 22, 2016
Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemiaFarzaneh Ghazavi, Barbara De Moerloose, Wouter Van Loocke, et al.
Scientific Reports|February 3, 2021
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemiaMattias Hofmans, Tim Lammens, Barbara Depreter, et al.
Haematologica|August 18, 2022
<i>In vivo</i> stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemiaMaaike Van Trimpont, Amanda M Schalk, Yanti De Visser, et al.
Pediatric Blood & Cancer|January 10, 2019
Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01Barbara De Moerloose, Ardine Reedijk, Geertruida H de Bock, et al.
Haematologica|August 3, 2019
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartmentBarbara Depreter, Karin E Weening, Karl Vandepoele, et al.
European Journal of Medical Genetics|February 12, 2023
European standard clinical practice - Key issues for the medical care of individuals with familial leukemiaAlisa Förster, Claudia Davenport, Nicolas Duployez, et al.
Cell Death & Disease|February 25, 2026
Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitorsIris H Nelen, Soetkin Leys, Sarah-Lee Bekaert, et al.
Frontiers in Immunology|January 9, 2019
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working GroupSimon Bomken, Jutte van der Werff Ten Bosch, Andishe Attarbaschi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2025
Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignanciesJette J Bakhuizen, Freerk van Dijk, Sebastian B B Bon, et al.
Pageof 8